Sudeep Pharma Limited
Sudeep Pharma Limited is a Private Indian company incorporated in 1989 and based in Gujarat, India. Sudeep Pharma Limited operates in Pharmaceuticals & Chemicals (NIC 24231) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
SUDEEP PHARMA LIMITED is the legal entity of Sudeep Pharma, Sudeep Nutrition and Sudeep Group.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Sudeep Pharma Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 24 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 26 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 23 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Sudeep Pharma Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 530928925 | State Bank of India(Bank) | ₹17.26 Cr | 12 Mar 2023 | Open |
| 894106770 | State Bank of India(Bank) | ₹24.70 Cr | 27 Jan 2019 | Satisfied |
| 143974453 | HDFC Bank Ltd(Bank) | ₹18.63 Cr | 04 Jul 2019 | Satisfied |
| 656173569 | ICICI Bank Ltd(Bank) | ₹10.83 Cr | 12 Mar 2022 | Satisfied |
| 598779895 | Axis Bank Ltd(Bank) | ₹7.50 Cr | 27 Jan 2020 | Open |
Charge IDs, lenders & amounts for Sudeep Pharma Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹6.53 Cr | ₹-21.97 L | ₹3.50 Cr | ₹8.86 Cr | 140 |
| FY2023-24 | ₹5.53 Cr | ₹-16.86 L | ₹2.64 Cr | ₹7.31 Cr | 105 |
| FY2022-23 | ₹5.23 Cr | ₹-26.91 L | ₹3.82 Cr | ₹8.06 Cr | 271 |
| FY2021-22 | ₹4.09 Cr | ₹-13.40 L | ₹1.69 Cr | ₹4.79 Cr | 143 |
Audited financials & ratios for Sudeep Pharma Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹6.53 Cr | ₹5.53 Cr | ₹5.23 Cr | ₹4.09 Cr |
| Other income | ₹8.58 L | ₹6.61 L | ₹4.95 L | ₹5.82 L |
| Total income | ₹6.62 Cr | ₹5.59 Cr | ₹5.28 Cr | ₹4.15 Cr |
| Total expenses | ₹6.90 Cr | ₹5.81 Cr | ₹5.62 Cr | ₹4.32 Cr |
| Profit before tax | ₹-28.56 L | ₹-21.91 L | ₹-34.98 L | ₹-17.42 L |
| Profit / (Loss) after tax | ₹-21.97 L | ₹-16.86 L | ₹-26.91 L | ₹-13.40 L |
| Balance sheet | ||||
| Equity / Net worth | ₹3.50 Cr | ₹2.64 Cr | ₹3.82 Cr | ₹1.69 Cr |
| Borrowings | ₹2.26 Cr | ₹94.98 L | ₹1.86 Cr | ₹90.75 L |
| Current liabilities | ₹2.18 Cr | ₹1.75 Cr | ₹1.75 Cr | ₹1.70 Cr |
| Total liabilities | ₹5.36 Cr | ₹4.67 Cr | ₹4.24 Cr | ₹3.10 Cr |
| Current assets | ₹3.36 Cr | ₹2.63 Cr | ₹3.75 Cr | ₹2.33 Cr |
| Cash & equivalents | ₹1.21 Cr | ₹31.90 L | ₹70.94 L | ₹37.27 L |
| Total assets | ₹8.86 Cr | ₹7.31 Cr | ₹8.06 Cr | ₹4.79 Cr |
| Employees | 140 | 105 | 271 | 143 |
Audited financials & ratios for Sudeep Pharma Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹6.53 Cr | +3.7% | +8.1% | +7.1% |
| Profit after Tax | ₹-21.97 L | +10.5% | -0.2% | +14.0% |
| Net Worth | ₹3.50 Cr | +19.4% | +20.7% | +2.1% |
| Employees | 140 | +7.5% | +9.9% | +14.0% |
Audited financials & ratios for Sudeep Pharma Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹6.53 Cr | ₹-21.97 L | -3.36% | +22.77% | -6.28% | -2.48% | 0.65 | ₹4.67 L |
| FY2023-24 | ₹5.53 Cr | ₹-16.86 L | -3.05% | +36.11% | -6.38% | -2.31% | 0.36 | ₹5.26 L |
| FY2022-23 | ₹5.23 Cr | ₹-26.91 L | -5.15% | -12.70% | -7.05% | -3.34% | 0.49 | ₹1.93 L |
| FY2021-22 | ₹4.09 Cr | ₹-13.40 L | -3.27% | +5.15% | -7.93% | -2.80% | 0.54 | ₹2.86 L |
Audited financials & ratios for Sudeep Pharma Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 4 | 95,98,220 | 83.57% |
| Institutional Investors | 2 | 4,59,127 | 4.00% |
| Public & Others | 7 | 14,28,004 | 12.43% |
Promoter, institutional & public holding for Sudeep Pharma Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
30 peersExternal data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.